Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boster Bio is a life science tools and services company focused on antibodies, ELISA kits, recombinant proteins, reagents, and contract research services for biomedical research. Founded in 1993, the company markets itself as an antibody manufacturer and provides validated products for applications such as immunohistochemistry, western blotting, ELISA, flow cytometry, and multiplex assays. In addition to catalog products, Boster offers custom antibody generation, recombinant protein expression, analytical services, assay development, and gene-editing-related services. The business appears to serve academic, biotechnology, pharmaceutical, and diagnostic research customers rather than developing a therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bosyer Biological Technology.